Medomie Pharma
Making Innovation Accessible
Medomie is an active leading commercial pharma partner in Israel and the Palestinian Authority for innovative Biosimilar and niche generic products.
Who We Are
Who We Are
Medomie is a privately owned pharmaceutical company, focused on distributing and selling innovative, brand, biosimilar and niche generic products for patients in Israel and The Palestinian Authority.
Our expertise lies in rapidly and efficiently identifying unexploited potential in known and unknown molecules and bringing them to market quickly.
Our Vision
Medomie is devoted to outstanding performance and growth and is set to become one of the top 5 local pharmaceutical companies. Our team is committed to becoming a leading pharmaceutical player with a unique portfolio of essential high-quality, difficult-to-get niche pharmaceutical products. We specialize in finding those specific molecules with added value, both for our partners and the local markets.
Our product portfolio consists of a diverse range of molecules for the treatment of conditions in the areas of oncology, endocrinology, hematology, cardiology, neurology, gastroenterology and more. This is in addition to a significant growing portfolio of biosimilars, brand and generic products.
Medomie Is Focused on Developing and Bringing To the Market
Highest Quality Biosimilars
With the potential to offer targeted therapies and reduced side effects, the drive towards biologics is necessary.
Biosimilars, like generics, are also cheaper versions of costly name-brand drugs, but they are modelled after drugs that use living organisms as important ingredients instead of using chemical processes.
We want to improve patient access to safe and effective biological medicines with proven quality.
Medomie is open for Cooperation!
At Medomie, We Value Partnerships And Collaboration. Our Strategy Relies Heavily
On Our Selection Of Partners And Successful Partnerships Around The World.
Medomie is setting new rules for a better world and providing access for medicine with strict quality assurance and full pharmacovigilance to the benefit of our partners and patients.
